Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004).

Toyoda M, Ajiki T, Fujiwara Y, Nagano H, Kobayashi S, Sakai D, Hatano E, Kanai M, Nakamori S, Miyamoto A, Tsuji A, Kaihara S, Ikoma H, Takemura S, Toyokawa H, Terajima H, Morita S, Ioka T.

Cancer Chemother Pharmacol. 2014 Jun;73(6):1295-301. doi: 10.1007/s00280-014-2431-y. Epub 2014 Mar 11.

2.

Feasibility and efficacy of gemcitabine plus cisplatin combination therapy after curative resection for biliary tract cancer.

Kainuma O, Miura F, Furukawa D, Yamamoto H, Cho A, Sano K, Nakagohri T, Asano T.

J Hepatobiliary Pancreat Sci. 2015 Nov;22(11):789-94. doi: 10.1002/jhbp.283. Epub 2015 Aug 30.

PMID:
26234468
3.

Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer.

Watanabe A, Kida M, Miyazawa S, Iwai T, Okuwaki K, Kaneko T, Yamauchi H, Takezawa M, Imaizumi H, Koizumi W.

World J Gastroenterol. 2015 May 21;21(19):5979-84. doi: 10.3748/wjg.v21.i19.5979.

4.

Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002).

Kanai M, Hatano E, Kobayashi S, Fujiwara Y, Sakai D, Kodama Y, Ajiki T, Nagano H, Ioka T.

Cancer Chemother Pharmacol. 2012 May;69(5):1181-8. doi: 10.1007/s00280-011-1818-2. Epub 2012 Jan 12.

PMID:
22237958
5.

Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.

Shoji H, Morizane C, Sakamoto Y, Kondo S, Ueno H, Takahashi H, Ohno I, Shimizu S, Mitsunaga S, Ikeda M, Okusaka T.

Jpn J Clin Oncol. 2016 Feb;46(2):132-7. doi: 10.1093/jjco/hyv179. Epub 2015 Dec 18.

PMID:
26685318
6.

A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures.

Takahara T, Nitta H, Hasegawa Y, Itou N, Takahashi M, Nishizuka S, Wakabayashi G.

Cancer Chemother Pharmacol. 2012 May;69(5):1127-33. doi: 10.1007/s00280-011-1805-7. Epub 2011 Dec 30.

PMID:
22207029
7.

A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002).

Kanai M, Hatano E, Kobayashi S, Fujiwara Y, Marubashi S, Miyamoto A, Shiomi H, Kubo S, Ikuta S, Yanagimoto H, Terajima H, Ikoma H, Sakai D, Kodama Y, Seo S, Morita S, Ajiki T, Nagano H, Ioka T.

Cancer Chemother Pharmacol. 2015 Feb;75(2):293-300. doi: 10.1007/s00280-014-2648-9. Epub 2014 Dec 5.

8.

Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study.

Kobayashi S, Nagano H, Sakai D, Eguchi H, Hatano E, Kanai M, Seo S, Taura K, Fujiwara Y, Ajiki T, Takemura S, Kubo S, Yanagimoto H, Toyokawa H, Tsuji A, Terajima H, Morita S, Ioka T.

Cancer Chemother Pharmacol. 2014 Oct;74(4):699-709. doi: 10.1007/s00280-014-2543-4. Epub 2014 Jul 30.

PMID:
25074036
9.

Phase I trial of oral S-1 combined with hepatic arterial infusion of gemcitabine in unresectable biliary tract cancer.

Ishiwatari H, Hayashi T, Yoshida M, Ono M, Sato T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.

Cancer Chemother Pharmacol. 2015 Apr;75(4):805-12. doi: 10.1007/s00280-015-2704-0. Epub 2015 Feb 17.

PMID:
25687990
10.

Pharmacokinetic Study of Adjuvant Gemcitabine Therapy for Biliary Tract Cancer following Major Hepatectomy (KHBO1101).

Fujiwara Y, Kobayashi S, Nagano H, Kanai M, Hatano E, Toyoda M, Ajiki T, Takashima Y, Yoshimura K, Hamada A, Minami H, Ioka T.

PLoS One. 2015 Dec 3;10(12):e0143072. doi: 10.1371/journal.pone.0143072. eCollection 2015.

11.

A Multicenter Phase II Study of Gemcitabine plus S-1 Chemotherapy for Advanced Biliary Tract Cancer.

Arima S, Shimizu K, Okamoto T, Toki M, Suzuki Y, Okano N, Naruge D, Kawai K, Kobayashi T, Kasuga A, Kitamura H, Takasu A, Nagashima F, Sugiyama M, Furuse J.

Anticancer Res. 2017 Feb;37(2):909-914.

PMID:
28179351
12.

Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer Patients Treated with Gemcitabine Plus Cisplatin Combination Therapy Followed by Radical Surgery.

Kato A, Shimizu H, Ohtsuka M, Yoshitomi H, Furukawa K, Takayashiki T, Nakadai E, Kishimoto T, Nakatani Y, Yoshidome H, Miyazaki M.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1093-9. doi: 10.1245/s10434-015-4768-9. Epub 2015 Aug 4.

PMID:
26240009
13.

Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer.

Uwagawa T, Sakamoto T, Abe K, Okui N, Hata D, Shiba H, Futagawa Y, Aiba K, Yanaga K.

Cancer Chemother Pharmacol. 2015 Jan;75(1):191-6. doi: 10.1007/s00280-014-2636-0. Epub 2014 Nov 25.

PMID:
25422155
14.

A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.

Bridgewater J, Lopes A, Beare S, Duggan M, Lee D, Ricamara M, McEntee D, Sukumaran A, Wasan H, Valle JW.

BMC Cancer. 2016 Feb 24;16:153. doi: 10.1186/s12885-016-2174-8. Erratum in: BMC Cancer. 2016;16(1):369.

15.

Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer.

Sasaki T, Isayama H, Nakai Y, Mizuno S, Yamamoto K, Yagioka H, Yashima Y, Kawakubo K, Kogure H, Togawa O, Matsubara S, Sasahira N, Hirano K, Tsujino T, Tada M, Omata M, Koike K.

Invest New Drugs. 2011 Dec;29(6):1488-93. doi: 10.1007/s10637-010-9485-4. Epub 2010 Jul 6.

PMID:
20607585
16.
17.

Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer.

Moriwaki T, Ishida H, Araki M, Endo S, Yoshida S, Kobayashi M, Hamano Y, Sugaya A, Shimoyamada M, Hasegawa N, Imanishi M, Ito Y, Sato D, Hyodo I.

J Hepatobiliary Pancreat Sci. 2015 Sep;22(9):669-74. doi: 10.1002/jhbp.255. Epub 2015 Apr 15.

PMID:
25877225
18.

A retrospective study of chemotherapy with cisplatin plus gemcitabine after the failure of gemcitabine monotherapy for biliary tract cancer.

Kameda R, Ando T, Kobayashi S, Ueno M, Ohkawa S.

Jpn J Clin Oncol. 2013 Jun;43(6):636-40. doi: 10.1093/jjco/hyt059. Epub 2013 Apr 25.

PMID:
23619988
19.

Chemotherapy with gemcitabine plus cisplatin in patients with advanced biliary tract carcinoma at Chang Gung Memorial Hospital: a retrospective analysis.

Wu CE, Hsu HC, Shen WC, Lin YC, Wang HM, Chang JW, Chen JS.

Chang Gung Med J. 2012 Sep-Oct;35(5):420-7.

PMID:
23127347
20.

Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancer.

Lee S, Oh SY, Kim BG, Kwon HC, Kim SH, Rho MH, Kim YH, Rho MS, Jeong JS, Kim HJ.

Am J Clin Oncol. 2009 Aug;32(4):348-52. doi: 10.1097/COC.0b013e31818c08ff.

PMID:
19363436

Supplemental Content

Support Center